bucladesine has been researched along with enprofylline in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 2 (66.67) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Arner, P; Hellmér, J; Marcus, C; Sonnenfeld, T | 1 |
Arner, P; Engfeldt, P; Goldinger, M; Marcus, C | 1 |
Crowley, JJ; Cusack, BJ; Nielson, CP; Vestal, RE | 1 |
3 other study(ies) available for bucladesine and enprofylline
Article | Year |
---|---|
Mechanisms for differences in lipolysis between human subcutaneous and omental fat cells.
Topics: Abdomen; Adenosine Deaminase; Adipose Tissue; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Bucladesine; Catecholamines; Clonidine; Colforsin; Dose-Response Relationship, Drug; Female; Humans; Lipolysis; Male; Middle Aged; Norepinephrine; Omentum; Radioligand Assay; Receptors, Adrenergic, beta; Skin; Xanthines | 1992 |
Effects of lipolytic and antilipolytic agents on glucose transport in human fat cells.
Topics: Adenylyl Cyclase Inhibitors; Adipose Tissue; Anti-Inflammatory Agents, Non-Steroidal; Biological Transport; Bucladesine; Cells, Cultured; Clonidine; Colforsin; Dinoprostone; Dose-Response Relationship, Drug; Drug Interactions; Glucose; Humans; Insulin; Lipolysis; Niacin; Phenylisopropyladenosine; Xanthines | 1991 |
Therapeutic concentrations of theophylline and enprofylline potentiate catecholamine effects and inhibit leukocyte activation.
Topics: 1-Methyl-3-isobutylxanthine; Adenosine; Adult; Bucladesine; Calcimycin; Calcium; Catecholamines; Dinoprostone; Dose-Response Relationship, Drug; Drug Synergism; Humans; Isoproterenol; Middle Aged; Neutrophils; Prostaglandins E; Theophylline; Xanthines | 1986 |